-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$78.25216.29% Upside
Instil Bio, Inc. Frequently Asked Questions
-
What analysts cover Instil Bio, Inc.?
Instil Bio, Inc. has been rated by research analysts at Robert W. Baird, H.C. Wainwright, Jefferies, Morgan Stanley in the past 90 days.